Navigating FDA’s Draft Guidance for AI-Enabled Medical Devices

A look at how FDA's new draft guidance outlines recommendations for lifecycle management and marketing submissions of AI-enabled medical devices, emphasizing a total product lifecycle (TPLC) approach to address transparency, bias, data management, and risk management throughout the device’s development, deployment, and ongoing monitoring.